Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators-Reference-Cited by-同舟云学术

Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators

Published:2015-07-01 Issue:19 Volume:58 Page:7611-7633
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhan Peng¹,Itoh Yukihiro²,Suzuki Takayoshi²³,Liu Xinyong¹

Affiliation:

1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, P. R. China

2. Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 1-5 Shimogamohangi-Cho, Sakyo-Ku, Kyoto 606-0823, Japan

3. CREST, Japan Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan

Funder

Shandong Province

Core Research for Evolutional Science and Technology, Japan Science and Technology Agency

Takeda Science Foundation

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Uehara Memorial Foundation

Ministry of Education of the People's Republic of China

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00229

Reference92 articles.

1. Selectively Nonselective Kinase Inhibition: Striking the Right Balance

2. Selective and potent small-molecule inhibitors of PI3Ks

3. Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies

4. Selective JAK inhibitors

5. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of novel factor XIa Inhibitors with bicyclic isoquinoline and naphthalene fragments;Medicinal Chemistry Research;2024-05-30

2. Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands;Acta Pharmaceutica Sinica B;2024-05

3. Design and Synthesis of Novel Factor XIa Inhibitors with Bicyclic Isoquinoline and Naphthalene Fragments;2024-03-14

4. Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody;European Journal of Medicinal Chemistry;2024-03

5. Cracking a cancer code DNA methylation in epigenetic modification: an in-silico approach on efficacy assessment of Sri Lanka-oriented nutraceuticals;Journal of Biomolecular Structure and Dynamics;2024-02-29